文献速递生殖医学

去伪存真:基于抗体的DNA碎片化精子去除法

Separating the chaff from the wheat: antibody-based removal of DNA-fragmented sperm.
PubMed 文献 · Hum Reprod · 2023-01-01

本研究纳入133例因不孕就诊的男性,评估靶向附睾精子结合蛋白1(ELSPBP1)的免疫磁珠分选能否去除DNA碎片化精子。结果显示高精子DNA碎片(SDF)男性精子ELSPBP1水平更高,ELSPBP1阴性组分SDF持续较低。作者认为该技术为ART前精子优选提供了新分子方法,但仍需进一步研究验证安全性。

要点

  • 高SDF男性精子ELSPBP1水平高于低SDF对照组,精浆中无差异。
  • ELSPBP1阳性组分SDF高且变异大,配对阴性组分SDF持续较低。
  • ELSPBP1位于精子头部,可作为DNA碎片化的间接检测方法。

核心结论

  • ELSPBP1与高DNA碎片化精子相关,精子膜可反映DNA完整性改变。
  • 该发现可能为辅助生殖前精子优选提供新分子方法。
  • 检测精子结合的ELSPBP1可作为DNA碎片化的间接方法。

研究设计与样本

  • 研究招募267例因不孕就诊患者,排除后纳入133例,样本采集于2016年7月至2019年9月。
  • 52例样本用于评估精子ELSPBP1水平(子研究1),41例用于确定ELSPBP1在人精子中的定位(子研究2)。
  • 40例样本用于靶向ELSPBP1的免疫磁珠分选,制备ELSPBP1阴性及阳性组分(子研究3)。
  • 子研究1采用蛋白质印迹法评估ELSPBP1水平,子研究2采用免疫细胞化学定位,子研究3采用碱性彗星实验测定SDF。

主要发现

  • 高SDF男性精子ELSPBP1水平高于低SDF对照组,精浆中两组无差异。
  • ELSPBP1定位于人精子头部区域。
  • ELSPBP1阳性组分SDF水平高且变异大,其配对的ELSPBP1阴性组分SDF持续较低。

临床怎么用

  • 作者认为该技术仍属临床前研究,需进一步研究证明在ART中使用的安全性。
  • 作者认为仍需临床试验才能将这些发现外推至ART结局。

局限性

  • 本研究未验证ELSPBP1在其他精子功能异常如顶体完整性或线粒体活性中的水平。
  • 本研究仍为临床前研究,旨在证明ELSPBP1选择低DNA碎片精子的概念验证。
  • 需进一步研究证明在ART中使用的安全性。
  • 未评估精子组分的活力。
  • 仍需临床试验才能将这些发现外推至ART结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is it possible to remove sperm with damaged DNA from a semen sample? SUMMARY ANSWER: By using immunomagnetic cell sorting that targets the sperm head-bound epididymal sperm-binding protein 1 (ELSPBP1), it was possible to produce an ELSPBP1(-) sperm fraction characterized by consistently lower levels of sperm DNA fragmentation (SDF). WHAT IS KNOWN ALREADY: In bovines, ELSPBP1 is bound to dead spermatozoa. Human ejaculates with high SDF have increased detected levels of sperm ELSPBP1 when compared to ejaculates with low native SDF. STUDY DESIGN, SIZE, DURATION: We recruited 267 patients who were referred to the clinic for conjugal infertility. After applying exclusion criteria, such as fever within 90 days of the study, history of systemic diseases, alterations or surgical interventions to the genital tract and use of cigarette or drugs, a total of 133 patients were included. A total of 52 samples were used for the evaluation of sperm ELSPBP1 levels (Sub-study 1), 41 samples for determination of ELSPBP1 location in human sperm (Sub-study 2), and 40 samples for immunomagnetic cell sorting targeting ELSPBP1, to produce ELSPBP1(-) (without ELSPBP1) and ELSPBP1(+) (with ELSPBP1) fractions (Sub-study 3). Samples were collected between July 2016 and September 2019. PARTICIPANTS/MATERIALS, SETTING, METHODS: In Sub-study 1, sperm ELSPBP1 levels were assessed by western blotting. For Sub-study 2, ELSPBP1 was localized in sperm by immunocytochemistry. Finally, for Sub-study 3, sperm were selected based on incubation of semen samples with antibody-coated magnetic microspheres targeting ELSPBP1. Two fractions were produced (with or without ELSPBP1), and these sub-populations were submitted to an alkaline Comet assay for determination of SDF. MAIN RESULTS AND THE ROLE OF CHANCE: Men with high SDF presented higher sperm ELSPBP1 levels when compared to the control group (low SDF), while no difference between groups was observed in seminal plasma. ELSPBP1 was located in the head region of human sperm. The ELSPBP1(+) fractions presented high and variable levels of SDF, while their paired ELSPBP(-) fractions presented consistently low SDF. LIMITATIONS, REASONS FOR CAUTION: This work did not validate the levels of ELSPBP1 in other functional alterations of sperm, such as acrosome integrity or mitochondrial activity. Moreover, this is still a pre-clinical study, intended to demonstrate proof-of-concept that ELSPBP1 selects sperm with low DNA fragmentation; further investigation is warranted to demonstrate safety for use in ART. Sperm fractions were not assessed for sperm vitality. A clinical trial is still necessary for these findings to be extrapolated to outcomes in ART. WIDER IMPLICATIONS OF THE FINDINGS: Our findings demonstrate that ELSPBP1 is associated with sperm with higher levels of DNA fragmentation. The finding that the sperm membrane can reflect alterations in DNA integrity could give rise to a novel molecular method for sperm preparation prior to use of assisted reproductive procedures. Moreover, the detection of sperm-bound ELSPBP1 could serve as an indirect method for the determination of DNA fragmentation. STUDY FUNDING/COMPETING INTEREST(S): L.B.B. was a recipient of a Ph.D. scholarship from the Sao Paulo Research Foundation-FAPESP (process number 2016/05487-3). R.P.B. is a recipient of a Scientific Productivity scholarship from the Brazilian National Council for Scientific and Technological Development-CNPq (process number 306705/2017-6). The authors have no conflict of interest to disclose. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Belardin LB, Antoniassi MP, Camargo M, et al. Separating the chaff from the wheat: antibody-based removal of DNA-fragmented sperm. Hum Reprod. 2023. PMID: 36539256. doi:10.1093/humrep/deac260

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。